Date & Time: 7th August 2025, 11am UTC


  • Users' discussions about the SNOMED International Drug Model and National Drug Extension Model.

Attendees:



Link: DEUSG Zoom Meeting Link


Link:

Passcode:


Discussion items                                                              **DRAFT**

Item

Description

Mins

Owner

Notes & Actions

1Opening5 min

Welcome & Notification of Recording

2Unit of Measure - rationalisation of concepts15 minOverview of proposal from UK, and group discussion/feedback
3Additional Attributes15 min

1. Yong has added a comment to the discussion board:
https://confluence.ihtsdotools.org/display/USRG/Additional+Attributes+for+National+Drug+Extensions
This includes a proposed new MRCM for 30465011000036106 |Has container type (attribute)|. Yong has raised questions regarding the domain, range (especially with respect to specific physical object values), and cardinality (also consider multi-container products, subpacks, and the implications for classification).

2. The attributes list from Canada is also available on the discussion board. Additional relevant content can be found on this page:
https://confluence.ihtsdotools.org/display/USRG/Medication+MRCM+Extensions

What are members requirements in the area of additional attributes?

4Substances Co-Ordination Update15 minKrista Lilly 
5AOB5 min

6Topic Back log

  • Less Granular Clinical Drug
  • Elemental Substances (Matt, AUS)
  • Substances Co-ordination (MF/2025 Priority topic)
    • Step 1: Substances in multiple extensions Batch promotions complete, SI review and authoring underway
    • Step 2: Substances in one extension
    • Step 3: Ongoing Substance Co-ordination (capturing at regulator level)
  • Medication Stopped v Medication Discontinued (Karen, SI)
  • Medicinal Product promotion co-ordination (Oslo group discussion as linked to substances work + ES)
  • Top level children of 373873005 |Pharmaceutical / biologic product| hierarchy - are members using/how are members using? (AUS) 
  • Increase range of has active ingredient to include microorganisms and natural products (Guillermo)
  • Link between Substances and the organism they come from (Cat dander protein → Cat organism) see PCP-68
  • Units of Measure - proposal for rationalisation of concepts (Emma, UK)


Done or in progress:

  • Hydration Subsumption 'Option 3' proposed by DEUSG for communication/consultation with MAG and EAG
  • Group Input on Patch Strength Representation Briefing note now being implemented
  • Dose Form Intended Site v Route of Administration (BEL) Pending implementation use-cases associated with intended site
  • Drug extension MRCM attributes (CA, AUS) SI facilitating links with CA and AUS for cross-promotion, next steps: other countries to be invited to add to catalogue
  • Value range of a |Has container type| attribute (Linda, CA)
  • Routes of Administration - Implementation Considerations (Mia, NZ)